Align Technology - ALGN Stock Forecast, Price & News

Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign moderate, lite and express packages, and Invisalign go; and non-case products include retention products, Invisalign training fees, and sales of ancillary products, such as cleaning material, and adjusting tools used by dental professionals during the course of treatment. The Scanners and Services segment offers iTero scanner, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers. This segment also provides computer-aided design and computer-aided manufacturing services; ancillary products, such as disposable sleeves for the wand; iTero model and dies; third party scanners and digital scans; Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan. The company sells its products in the United States, Switzerland, China, and internationally. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.

Wall Street Analyst Weigh In

Several research analysts have weighed in on the company. UBS Group dropped their price target on Align Technology from $380.00 to $370.00 and set a "buy" rating for the company in a research note on Friday, July 29th. Evercore ISI reduced their price target on shares of Align Technology from $310.00 to $285.00 in a report on Thursday, July 28th. TheStreet downgraded shares of Align Technology from a "b-" rating to a "c+" rating in a report on Monday, April 25th. Credit Suisse Group reduced their target price on Align Technology from $722.00 to $418.00 in a report on Wednesday, May 4th. Finally, Piper Sandler cut their price target on Align Technology from $440.00 to $370.00 and set an "overweight" rating for the company in a report on Friday, July 22nd. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and eight have assigned a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $361.67.

Align Technology Trading Up 1.4 %

NASDAQ:ALGN traded up $4.00 during midday trading on Thursday, hitting $281.66. 554,053 shares of the company traded hands, compared to its average volume of 987,600. The firm has a market capitalization of $22.00 billion, a P/E ratio of 35.51, a P/E/G ratio of 8.58 and a beta of 1.78. The firm's fifty day moving average is $261.15 and its 200-day moving average is $349.59. Align Technology has a 12-month low of $225.86 and a 12-month high of $737.45.

Align Technology (NASDAQ:ALGN - Get Rating) last released its earnings results on Wednesday, July 27th. The medical equipment provider reported $2.00 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.23 by ($0.23). The firm had revenue of $969.60 million during the quarter, compared to the consensus estimate of $986.05 million. Align Technology had a return on equity of 17.47% and a net margin of 15.52%. Align Technology's revenue was down 3.0% compared to the same quarter last year. During the same quarter last year, the business posted $2.51 EPS. On average, research analysts expect that Align Technology will post 7.8 EPS for the current fiscal year.